Partnership Awards support researchers collaborating across academia, industry, and nonprofit organizations on translational research to advance melanoma prevention, diagnosis, staging, and treatment.
Established Investigator Awards support senior investigators conducting innovative, translational melanoma research to advance prevention, diagnosis, staging, and treatment in the near and intermediate future.
Team Science Awards support multidisciplinary teams pursuing innovative, translational melanoma research to advance prevention, diagnosis, staging, and treatment through collaborative science.
Accelerator Awards support investigators pursuing ambitious four-year neuroendocrine cancer research to advance early detection, develop new therapies, and match treatments to individual tumor biology.
Community-Academic Partnership Awards support community organizations and academic researchers in generating and implementing healthcare evidence to address community-identified health needs.
The Mark Foundation Endeavor Awards support multidisciplinary teams conducting innovative collaborative research to advance cancer prevention, diagnosis, and treatment.